<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0123-9392</journal-id>
<journal-title><![CDATA[Infectio]]></journal-title>
<abbrev-journal-title><![CDATA[Infect.]]></abbrev-journal-title>
<issn>0123-9392</issn>
<publisher>
<publisher-name><![CDATA[Asociación Colombiana de Infectología.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0123-93922017000100019</article-id>
<article-id pub-id-type="doi">10.22354/in.v21i1.637</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Epidemiología de la enfermedad por meningococo en Colombia]]></article-title>
<article-title xml:lang="en"><![CDATA[Epidemiology of meningococcal disease in Colombia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Velez-van-Meerbeke]]></surname>
<given-names><![CDATA[Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Medina-Silva]]></surname>
<given-names><![CDATA[Nicolás]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Besada-Lomban]]></surname>
<given-names><![CDATA[Sandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mojica-Madero]]></surname>
<given-names><![CDATA[José Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad del Rosario Escuela de Medicina y Ciencias de la Salud Grupo de Investigación en Neurociencias]]></institution>
<addr-line><![CDATA[Bogotá D.C]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Sanofi Pasteur  ]]></institution>
<addr-line><![CDATA[Bogotá D.C]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>01</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>01</month>
<year>2017</year>
</pub-date>
<volume>21</volume>
<numero>1</numero>
<fpage>19</fpage>
<lpage>24</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0123-93922017000100019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0123-93922017000100019&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0123-93922017000100019&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Describir la situación epidemiológica de la enfermedad meningocócica en Colombia.  Material y métodos: Estudio descriptivo que recopiló información de diferentes fuentes pertenecientes al Sistema Nacional de Vigilancia en Salud Pública. Las variables fueron analizadas de forma descriptiva y se calcularon las tasas de incidencia cuando los datos requeridos estuvieron disponibles.  Resultados: Durante el periodo 2005-2011 se notificaron 1.065 casos, lo que representó un promedio anual de incidencia de 0,36/100.000 habitantes. De estos, se confirmaron tan solo el 46%, lo que apunta a la existencia de una importante brecha de notificación y confirmación. La mayor incidencia se encontró en menores de un año (5,4-6,9/100.000 habitantes) y el 50% de los casos se presentaron en menores de 10 años.  Discusión: La Neisseria meningitidis serogrupo B representó la mayor proporción de los aislamientos; sin embargo, en los últimos años los serogrupos Y y C han tenido un repunte importante. Los síntomas fueron en general inespecíficos, el curso de la enfermedad fue rápido y la letalidad fue alta (13,3%).  Conclusiones: Existe la necesidad de mejorar las herramientas disponibles para la vigilancia. Las acciones preventivas deben estar dirigidas a lactantes y niños, con protección contra los serogrupos Y y C. Es necesaria la investigación de estrategias contra el serogrupo B.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objectives: The purpose of this paper was to describe the epidemiology of meningococcal disease in Colombia.  Materials and methods: This was a descriptive study based on data from various sources in the National Surveillance System. The variables were analysed descriptively and the incidence rates were estimated when the required data were available.  Results: During the 2005-2011 period, 1,065 cases were reported, which represented an annual mean incidence of 0.36/100.000 inhabitants. Of these, only 46% were confirmed, which reveals a gap between reporting and confirmation. The greatest incidence was observed in infants younger than one year (5.4-6.9/100,000) and 50% of the cases occurred in children under 10 years of age.  Discussion: Neisseria meningitidis serogroup B represented the greatest proportion of isolates; however, serogroups Y and C have been increasing recently. The symptoms were non-specific, the course of the disease was rapid and the lethality high (13.3%).  Conclusions: There is a need to improve the available tools for diagnosis and surveillance. Prevention must be oriented toward infants, toddlers and children including protection against serogroups C and Y. Research into strategies for prevention against serogroup B is also necessary.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Meningitis meningocócica]]></kwd>
<kwd lng="es"><![CDATA[Epidemiología]]></kwd>
<kwd lng="es"><![CDATA[Salud Pública]]></kwd>
<kwd lng="es"><![CDATA[Vacunación]]></kwd>
<kwd lng="en"><![CDATA[Meningococcal meningitis]]></kwd>
<kwd lng="en"><![CDATA[Epidemiology]]></kwd>
<kwd lng="en"><![CDATA[Public Health]]></kwd>
<kwd lng="en"><![CDATA[Vaccination]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Description and nomenclature of Neisseria meningitidis capsule locus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harrison]]></surname>
<given-names><![CDATA[OB]]></given-names>
</name>
<name>
<surname><![CDATA[Claus]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Bratcher]]></surname>
<given-names><![CDATA[HB]]></given-names>
</name>
<name>
<surname><![CDATA[Jolley]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
</person-group>
<source><![CDATA[Emerg Infect Dis]]></source>
<year>2013</year>
<volume>19</volume>
<page-range>566-73</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Meningococcal disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosenstein]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Perkins]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Stephens]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Popovic]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[N Engl J Med]]></source>
<year>2001</year>
<volume>344</volume>
<page-range>1378-88</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical recognition of meningococcal disease in children and adolescents]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ninis]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Perera]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mayon-White]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet]]></source>
<year>2006</year>
<volume>367</volume>
<page-range>397-403</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epidemic meningitis, meningococcaemia, and Neisseria meningitidis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stephens]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Greenwood]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Brandtzaeg]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet]]></source>
<year>2007</year>
<volume>369</volume>
<page-range>2196-210</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Erickson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[DeWals]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Infect Dis]]></source>
<year>1998</year>
<volume>26</volume>
<page-range>1159-64</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Global epidemiology of meningococcal disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harrison]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Trotter]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Ramsay]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<source><![CDATA[Vaccine]]></source>
<year>2009</year>
<volume>27</volume>
<page-range>B51-63</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epidemiology of meningococcal disease in Latin America: Current situation and opportunities for prevention]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sáfadi]]></surname>
<given-names><![CDATA[MAP]]></given-names>
</name>
<name>
<surname><![CDATA[Cintra]]></surname>
<given-names><![CDATA[OAL]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurol Res]]></source>
<year>2010</year>
<volume>32</volume>
<page-range>263-71</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The epidemiology of meningococcal disease in Latin America 1945-2010: An unpredictable and changing landscape]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Safadi]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez-Ayala]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jakel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wieffer]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Vyse]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Epidemiol Infect]]></source>
<year>2012</year>
<volume>9</volume>
<page-range>1-12</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Caracterización de aislamientos invasivos de S. pneumoniae, H. in&#64258;uenzae y N. meningitidis en América Latinay el Caribe: SIREVA II, 2000 2005]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gabastou]]></surname>
<given-names><![CDATA[J-M]]></given-names>
</name>
<name>
<surname><![CDATA[Agudelo]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Brandileone]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lemos]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Di Fabio]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Panam Salud Pública]]></source>
<year>2008</year>
<volume>24</volume>
<page-range>1-15</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Laboratory based surveillance of Neisseria meningitidis isolatesfrom disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ibarz-Pavon]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Lemos]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Gorla]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Regueira]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gabastou]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2012</year>
<volume>7</volume>
<page-range>e44102</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<collab>DIPLAS</collab>
<article-title xml:lang=""><![CDATA[Informe de situación: Enfermedad meningocócica (Semana epidemiológica 1 a 52)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dd]]></surname>
<given-names><![CDATA[Rdludv]]></given-names>
</name>
</person-group>
<collab>MINSAL</collab>
<source><![CDATA[Reporte de la unidad de vigilancia]]></source>
<year>2012</year>
<page-range>1</page-range><publisher-loc><![CDATA[Santiago ]]></publisher-loc>
<publisher-name><![CDATA[Departamento de epidemiología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Meningococcal disease: Always present. Serogroup changes in the Southern Cone]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Debbag]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Chilena Infectol]]></source>
<year>2012</year>
<volume>29</volume>
<page-range>587-94</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Estimatingcosts associated with a community outbreak of meningococcal disease in a Colombian Caribbean city]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinzon-Redondo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Coronell-Rodriguez]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz-Martinez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Guzman- Corena]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Constenla]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Alvis-Guzman]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[J Health Popul Nutr]]></source>
<year>2014</year>
<volume>32</volume>
<page-range>539-48</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epidemiologia de la enfermedad meningocócica en Colombia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espinal]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Upegui]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Infectio]]></source>
<year>1999</year>
<volume>3</volume>
<page-range>13</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Informe epidemiológico Nacional 2009]]></article-title>
<collab>INS</collab>
<collab>SIVIGILA</collab>
<source><![CDATA[Salud Sdvesp- INd]]></source>
<year>2010</year>
<page-range>87-90</page-range><publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Subdirección de vigilancia en salud pública, Instituto Nacional de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Boletín Epidemiológico Semanal (Semana epidemiológica 52, diciembre 25 al 31)]]></article-title>
<collab>INS</collab>
<collab>SIVIGILA</collab>
<source><![CDATA[Salud Sdvesp-INd]]></source>
<year>2011</year>
<page-range>6</page-range><publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Subdirección de vigilancia en salud pública, Instituto Nacional de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Boletín Epidemiológico Semanal (Semana Epidemiologica 1, enero 2 al 8)]]></article-title>
<collab>INS</collab>
<collab>SIVIGILA</collab>
<source><![CDATA[Salud Sdvesp-INd]]></source>
<year>2011</year>
<page-range>6</page-range><publisher-loc><![CDATA[Bogotá:Subdirección de vigilancia en salud pública ]]></publisher-loc>
<publisher-name><![CDATA[Instituto Nacional de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agudelo]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
</person-group>
<source><![CDATA[Aislamientos invasores de Streptococcus pneumoniae, Haemophilus in&#64258;uenzae, Neisseria meningitidis., Colombia. Resultados de la vigilancia por departamentos SIREVAII 2003-2012]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Instituto Nacional de Salud Dirección de Redes en Salud Pública, Subdirección de Laboratorio Nacionalde Referencia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinzon-Gutierrez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Informe del evento meningitis bacteriana, hasta el periodo epidemiológico XIII del año 2012]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Equipo Funcional Transmisibles, Grupo Inmunoprevenibles, Sub-dirección de Vigilancia y Control en Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acosta-Amador]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Informe &#64257;nal meningitis bacteriana (MBA), Colombia, 2013]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Grupo Inmunoprevenibles, Subdirección de Vigilancia y Control en Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reyes-Hernandez]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Informe final del evento meningitis aguda bacteriana (MBA) hasta el periodo epidemiológico XIII, Colombia, 2014]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Grupo Inmunoprevenibles, Subdirección de Vigilancia y Control en Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluation of a real-time polymerase chain reaction assay for the diagnosis of pneumococcal and meningococcal meningitis in a tertiary care hospital]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Gastel]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bruynseels]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Verstrepen]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Mertens]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Clin Microbiol Infect Dis]]></source>
<year>2007</year>
<volume>26</volume>
<page-range>651-3</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in Sao Paulo, Brazil]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sacchi]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Fukasawa]]></surname>
<given-names><![CDATA[LO]]></given-names>
</name>
<name>
<surname><![CDATA[Goncalves]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Salgado]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Shutt]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalhanas]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Toward a meningitis-free world]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Black]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pizza]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nissum]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rappuoli]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Sci Transl Med]]></source>
<year>2012</year>
<volume>4</volume>
<page-range>123ps5</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Serogroup Y meningococcal disease, Colombia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agudelo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sanabria]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ovalle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Emerg Infect Dis]]></source>
<year>2008</year>
<volume>14</volume>
<page-range>990-1</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abad]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Agudelo]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Brandileone]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Chanto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gabastou]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Hormazabal]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<source><![CDATA[J Infect]]></source>
<year>2009</year>
<volume>59</volume>
<page-range>104-14</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agudelo]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
</person-group>
<source><![CDATA[Aislamientos invasores de Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis,Colombia. Resultados de la vigilancia por departamentos SIREVA II 2003-2012]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The changing and dynamic epidemiology of meningococcal disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halperin]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Bettinger]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Greenwood]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Harrison]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Jelfs]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ladhani]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
</person-group>
<source><![CDATA[Vaccine]]></source>
<year>2012</year>
<volume>30</volume>
<page-range>B26-36</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harrison]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Pelton]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
<name>
<surname><![CDATA[Wilder-Smith]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Holst]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Safadi]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Vazquez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<source><![CDATA[Vaccine]]></source>
<year>2011</year>
<volume>29</volume>
<page-range>3363-71</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
